Clinical Trial Update: Safety and Efficacy Evaluation of MUC-1 CART in the Treatment of Intrahepatic Cholangiocarcinoma [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial evaluating MUC-1 CAR T cells for intrahepatic cholangiocarcinoma across Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intrahepatic Cholangiocarcinoma

Drugs mentioned

• MUC-1 CART (MUC-1 CAR T)

Snippet

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University | Conditions: Intrahepatic Cholangiocarcinoma | Phase 1, Phase 2 | Status: UNKNOWN